All > Smoking > Smoking Cessation

Integrated intervention of smoking cessation and breastfeeding for Smoking/Cigarette Smoking

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Division of Behavioral Medicine Department of Pediatrics Jacobs School of Medicine and Biomedical Sciences State University of New York at Buffalo, Buffalo, NYSmoking/Cigarette Smoking+1 MoreIntegrated intervention of smoking cessation and breastfeeding - Behavioral
Eligibility
18+
Female
What conditions do you have?
Select

Study Summary

This trial is testing whether an intervention that helps pregnant women quit smoking and breastfeed will be more successful than just helping them quit smoking.

Eligible Conditions
  • Smoking/Cigarette Smoking
  • Breastfeeding

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
ZTI-01 100 mg/kg
1
Pembrolizumab
1
Cohort 6: NDV-HXP-S high dose IM

Study Objectives

6 Primary · 0 Secondary · Reporting Duration: 6 months postpartum

Week 35
Breastfeeding intention
6 months postpartum
Breastfeeding duration
Breastfeeding frequency
Breastfeeding status
Formula duration
Smoking abstinence

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
ZTI-01 100 mg/kg
1
Pembrolizumab
1
Cohort 6: NDV-HXP-S high dose IM

Trial Design

2 Treatment Groups

Attention placebo control group
1 of 2
Integrated intervention
1 of 2

Active Control

Experimental Treatment

40 Total Participants · 2 Treatment Groups

Primary Treatment: Integrated intervention of smoking cessation and breastfeeding · Has Placebo Group · N/A

Integrated intervention
Behavioral
Experimental Group · 1 Intervention: Integrated intervention of smoking cessation and breastfeeding · Intervention Types: Behavioral
Attention placebo control group
Behavioral
ActiveComparator Group · 1 Intervention: Attention placebo control · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months postpartum

Who is running the clinical trial?

National Center for Advancing Translational Sciences (NCATS)NIH
199 Previous Clinical Trials
355,914 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,474 Previous Clinical Trials
24,586,491 Total Patients Enrolled
Xiaozhong WenLead Sponsor
Xiaozhong Wen, MD, PhDPrincipal InvestigatorState University of New York at Buffalo
1 Previous Clinical Trials
48 Total Patients Enrolled

Eligibility Criteria

Age 18+ · Female Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You must be able to understand and communicate in English through reading, listening, and speaking.
You have smoked cigarettes or cigars every day in the last week.
References

Frequently Asked Questions

Is this research endeavor currently open to enrollees?

"The trial in question is no longer enrolling patients, as indicated on clinicaltrials.gov. It was first posted on January 1st 2021 and its last edit took place on October 21st 2022. Fortunately, there are 91 alternative trials that are still open for enrolment at this time." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top